Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-24 4:53 PM View:  | Bridgebio Pharma, Inc. (BBIO) | 04-Jun-24 | Sale (Planned) | 1,500 | $31.30 | $46,950.00 | (14%) 10.5K to 9.0K | |
| 05-Jun-24 4:53 PM View: | Bridgebio Pharma, Inc. (BBIO) | 03-Jun-24 | Private Sale (Planned) | 1,000 | $28.84 | $28,842.50 | (9%) 11.5K to 10.5K | |
| 05-Mar-24 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Mar-24 | Private Sale (Planned) | 2,500 | $34.00 | $85,000.00 | (18%) 14.0K to 11.5K | |
| 20-Dec-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 18-Dec-23 | Private Sale (Planned) | 2,000 | $40.00 | $80,000.00 | (12%) 16.0K to 14.0K | |
| 05-Dec-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Dec-23 | Private Sale (Planned) | 2,500 | $29.40 | $73,500.00 | (14%) 18.5K to 16.0K | |
| 07-Sep-23 4:00 PM View: | Bridgebio Pharma, Inc. (BBIO) | 05-Sep-23 | Private Sale (Planned) | 2,500 | $30.00 | $75,000.00 | (12%) 21.0K to 18.5K | |
| 01-May-23 4:20 PM View: | Invitae Corp (NVTA) | 27-Apr-23 | Grant | 70,422 | -- | -- | 47% 150.8K to 221.22K | |
| 19-Jul-22 6:48 PM View: | Invitae Corp (NVTA) | 16-Jul-22 | Grant | 53,800 | -- | -- | 55% 97.0K to 150.8K | |
| 18-May-21 3:19 PM View: | Talis Biomedical Corp (TLIS) | 17-May-21 | Market Purchase | 11,000 | $10.11 | $111,210.00 | < 1% 1.71M to 1.72M | < 1% |
| 18-May-21 3:19 PM View: | Talis Biomedical Corp (TLIS) | 14-May-21 | Market Purchase | 9,000 | $10.16 | $91,440.00 | < 1% 1.7M to 1.71M | < 1% |
| 19-Feb-21 6:18 PM View: | Talis Biomedical Corp (TLIS) | 17-Feb-21 | Conversion | 1,390,060 | -- | -- | 100% 0 to 1.39M | |
| 19-Feb-21 6:18 PM View: | Talis Biomedical Corp (TLIS) | 17-Feb-21 | Purchase | 312,500 | $16.00 | $5,000,000.00 | 22% 1.39M to 1.7M | |
| 18-Feb-21 6:21 PM View: | Bridgebio Pharma, Inc. (BBIO) | 17-Feb-21 | Market Purchase | 16,000 | $62.50 | $1,000,000.00 | 320% 5.0K to 21.0K | 4% |
| 27-Aug-19 7:18 PM View: | Invitae Corp (NVTA) | 26-Aug-19 | Market Sale (Planned) | 40,000 | $24.59 | $983,405.00 | (1%) 3.49M to 3.45M | (91%) |
| 30-May-19 7:23 PM View: | Invitae Corp (NVTA) | 28-May-19 | Market Sale | 30,000 | $17.60 | $528,027.00 | (< 1%) 3.52M to 3.49M | (167%) |
| 27-Feb-19 2:13 PM View: | Invitae Corp (NVTA) | 25-Feb-19 | Market Sale | 30,000 | $19.10 | $572,997.00 | (< 1%) 3.55M to 3.52M | (146%) |
| 02-Apr-18 4:05 PM View: | Invitae Corp (NVTA) | 02-Apr-18 | Market Purchase | 44,444 | $4.50 | $199,998.00 | 1% 3.51M to 3.55M | 946% |
| 22-Nov-16 6:07 PM View: | Invitae Corp (NVTA) | 22-Nov-16 | Private Purchase | 66,666 | $6.00 | $399,996.00 | 2% 3.44M to 3.51M | 14% |
| 18-Feb-15 5:17 PM View: | Invitae Corp (NVTA) | 18-Feb-15 | Conversion | 3,439,560 | -- | -- | 100% 0 to 3.44M | |
| 12-Jul-12 2:42 PM View: | Genomic Health Inc. (GHDX) | 11-Jul-12 | Market Sale | 15,000 | $34.81 | $522,134.00 | (1%) 1.22M to 1.2M | (139%) |
| 12-Jul-12 2:42 PM View: | Genomic Health Inc. (GHDX) | 10-Jul-12 | Market Sale | 15,000 | $35.97 | $539,536.00 | (1%) 1.23M to 1.22M | (132%) |
| 13-Jun-12 2:46 PM View: | Genomic Health Inc. (GHDX) | 12-Jun-12 | Market Sale | 15,000 | $33.31 | $499,654.00 | (1%) 1.25M to 1.23M | (150%) |
| 13-Jun-12 2:46 PM View: | Genomic Health Inc. (GHDX) | 11-Jun-12 | Market Sale | 15,000 | $33.77 | $506,562.00 | (1%) 1.26M to 1.25M | (147%) |
| 14-May-12 5:39 PM View: | Genomic Health Inc. (GHDX) | 11-May-12 | Market Sale | 15,000 | $30.52 | $457,742.00 | (1%) 1.28M to 1.26M | (173%) |
| 14-May-12 5:39 PM View: | Genomic Health Inc. (GHDX) | 10-May-12 | Market Sale | 15,000 | $29.93 | $448,981.00 | (1%) 1.29M to 1.28M | (178%) |
| 12-Apr-12 5:36 PM View: | Genomic Health Inc. (GHDX) | 11-Apr-12 | Market Sale | 10,000 | $28.38 | $283,790.00 | (< 1%) 1.3M to 1.29M | (194%) |
| 12-Apr-12 5:36 PM View: | Genomic Health Inc. (GHDX) | 10-Apr-12 | Market Sale | 10,000 | $28.81 | $288,081.00 | (< 1%) 1.31M to 1.3M | (189%) |
| 14-Mar-12 1:21 PM View: | Genomic Health Inc. (GHDX) | 13-Mar-12 | Market Sale | 15,000 | $31.12 | $466,764.00 | (1%) 1.33M to 1.31M | (168%) |
| 14-Mar-12 1:21 PM View: | Genomic Health Inc. (GHDX) | 12-Mar-12 | Market Sale | 15,000 | $30.98 | $464,680.00 | (1%) 1.34M to 1.33M | (169%) |
| 17-Feb-12 8:05 PM View: | Genomic Health Inc. (GHDX) | 15-Feb-12 | Payment of Exercise | 629 | $28.97 | $18,222.10 | (< 1%) 1.34M to 1.34M | (188%) |
| 13-Feb-12 9:25 AM View: | Genomic Health Inc. (GHDX) | 10-Feb-12 | Market Sale | 10,000 | $26.25 | $262,495.00 | (< 1%) 1.35M to 1.34M | (217%) |
| 13-Feb-12 9:25 AM View: | Genomic Health Inc. (GHDX) | 09-Feb-12 | Market Sale | 10,000 | $26.10 | $261,029.00 | (< 1%) 1.36M to 1.35M | (219%) |
| 07-Feb-12 7:07 PM View: | Genomic Health Inc. (GHDX) | 05-Feb-12 | Grant | 4,600 | -- | -- | < 1% 1.36M to 1.36M | |
| 12-Jan-12 1:47 PM View: | Genomic Health Inc. (GHDX) | 11-Jan-12 | Market Sale | 10,000 | $27.56 | $275,612.00 | (< 1%) 1.37M to 1.36M | (202%) |
| 12-Jan-12 1:47 PM View: | Genomic Health Inc. (GHDX) | 10-Jan-12 | Market Sale | 10,000 | $27.35 | $273,530.00 | (< 1%) 1.38M to 1.37M | (205%) |
| 14-Dec-11 3:35 PM View: | Genomic Health Inc. (GHDX) | 13-Dec-11 | Market Sale | 10,000 | $27.01 | $270,078.00 | (< 1%) 1.39M to 1.38M | (208%) |
| 14-Dec-11 3:35 PM View: | Genomic Health Inc. (GHDX) | 12-Dec-11 | Market Sale | 10,000 | $27.57 | $275,652.00 | (< 1%) 1.4M to 1.39M | (202%) |
| 22-Nov-11 7:08 PM View: | Genomic Health Inc. (GHDX) | 18-Nov-11 | Gift | 30,000 | -- | -- | (2%) 1.41M to 1.38M | |
| 14-Nov-11 1:28 PM View: | Genomic Health Inc. (GHDX) | 11-Nov-11 | Market Sale | 10,000 | $27.53 | $275,280.00 | (< 1%) 1.44M to 1.43M | (203%) |
| 14-Nov-11 1:28 PM View: | Genomic Health Inc. (GHDX) | 10-Nov-11 | Market Sale | 10,000 | $26.95 | $269,549.00 | (< 1%) 1.45M to 1.44M | (209%) |
| 22-Nov-11 7:05 PM View: | Genomic Health Inc. (GHDX) | 11-Oct-11 | Market Sale | 10,000 | $22.60 | $225,985.00 | (< 1%) 1.46M to 1.45M | (269%) |
| 22-Nov-11 7:05 PM View: | Genomic Health Inc. (GHDX) | 10-Oct-11 | Market Sale | 10,000 | $23.06 | $230,608.00 | (< 1%) 1.47M to 1.46M | (261%) |
| 14-Sep-11 12:54 PM View: | Genomic Health Inc. (GHDX) | 13-Sep-11 | Market Sale | 10,000 | $20.90 | $209,032.00 | (< 1%) 1.48M to 1.47M | (299%) |
| 14-Sep-11 12:54 PM View: | Genomic Health Inc. (GHDX) | 12-Sep-11 | Market Sale | 10,000 | $20.72 | $207,237.00 | (< 1%) 1.49M to 1.48M | (302%) |
| 12-Aug-11 8:05 PM View: | Genomic Health Inc. (GHDX) | 11-Aug-11 | Market Sale | 10,000 | $24.40 | $243,979.00 | (< 1%) 1.5M to 1.49M | (241%) |
| 12-Aug-11 8:05 PM View: | Genomic Health Inc. (GHDX) | 10-Aug-11 | Market Sale | 10,000 | $24.48 | $244,751.00 | (< 1%) 1.51M to 1.5M | (240%) |
| 13-Jul-11 2:23 PM View: | Genomic Health Inc. (GHDX) | 12-Jul-11 | Market Sale | 10,000 | $27.17 | $271,653.00 | (< 1%) 1.51M to 1.5M | (207%) |
| 13-Jul-11 2:23 PM View: | Genomic Health Inc. (GHDX) | 11-Jul-11 | Market Sale | 10,000 | $27.56 | $275,558.00 | (< 1%) 1.52M to 1.51M | (202%) |
| 14-Jun-11 6:19 PM View: | Genomic Health Inc. (GHDX) | 13-Jun-11 | Market Sale | 10,000 | $25.37 | $253,698.00 | (< 1%) 1.53M to 1.52M | (228%) |
| 14-Jun-11 6:19 PM View: | Genomic Health Inc. (GHDX) | 10-Jun-11 | Market Sale | 10,000 | $26.01 | $260,140.00 | (< 1%) 1.54M to 1.53M | (220%) |